🇺🇸 FDA
Patent

US 10201603

Therapeutic compositions and methods for treating HIV including identification and manipulation of particular domains associated with immunogenicity

granted A61KA61K38/162A61K39/12

Quick answer

US patent 10201603 (Therapeutic compositions and methods for treating HIV including identification and manipulation of particular domains associated with immunogenicity) held by The Regents of the University of California expires Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61K, A61K38/162, A61K39/12, A61K39/21, A61P